Evidence map›Paper›PMID 9334376›Full record

ArticleThe Journal of experimental medicine1997

Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.

P D Katsikis, M E Garcia-Ojeda, J F Torres-Roca, I M Tijoe, C A Smith, L A Herzenberg, L A Herzenberg

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 184 citations in OpenAlex.

  1. Trial
  2. TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  3. Article
  4. Article
  5. The TRAIL: TRAILshort Axis in HIV Immunopathology.Critical reviews in immunology · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. HIV-1 immunopathogenesis: how good interferon turns bad.Clinical immunology (Orlando, Fla.) · 2007
    Review
  18. Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  19. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

P D KatsikisDepartment of Genetics, Stanford University School of Medicine, California 94305, USA. katsikis@auhs.edu
M E Garcia-Ojeda
J F Torres-Roca
I M Tijoe
C A Smith
L A Herzenberg
L A Herzenberg
Stanford University · US

Funding

GENETICS OF IMMUNOGLOBULINS AND LYMPHOCYTE MOLECULESR35CA042509 · NCI · STANFORD UNIVERSITY · PI HERZENBERG, LEONARD A · 1986 to 2000
$71k
FACS-PENGUIN: KNOWLEDGE BASE SUPPORT FOR FLOW CYTOMETRYR01LM004836 · NLM · STANFORD UNIVERSITY · PI HERZENBERG, LEONORE A. · 1989 to 1999
–
NCI NIH HHS CA 42509NLM NIH HHS LM 04836
6 · The paper itself

Abstract

Apoptosis of peripheral blood T cells has been suggested to play an important role in the pathogenesis of human immunodeficiency virus (HIV) infection. Spontaneous, Fas (CD95)-induced and activation-induced T cell apoptosis have all been described in peripheral blood mononuclear cell cultures of HIV-infected individuals. We have previously shown that activation-induced T cell apoptosis is Fas independent in peripheral blood T cells from HIV+ individuals. In this study, we extend and confirm these observations by using an inhibitor of interleukin-1 beta converting enzyme (ICE) homologues. We show that z-VAD-fmk, a tripeptide inhibitor of ICE homologues, can inhibit Fas-induced apoptosis of peripheral blood CD4(+) and CD8+ T cells from asymptomatic HIV+ individuals. z-VAD-fmk also inhibited activation (anti-CD3)- induced CD4+ and CD8+ T cell apoptosis (AICD) in some but not all asymptomatic HIV+ individuals. Apoptosis was measured by multiparameter flow cytometry. The z-VAD-fmk inhibitor also enhanced survival of T cells in anti-Fas or anti-CD3 antibody-treated cultures and inhibited DNA fragmentation. AICD that could be inhibited by z-VAD-fmk was Fas independent and could be inhibited with a blocking monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a recently described member of the TNF/nerve growth factor ligand family. The above findings show that Fas-induced T cell apoptosis is ICE dependent in HIV infection. AICD can be blocked by ICE inhibitors in some patients, and this AICD is mediated by TRAIL. These results show that TRAIL can be a mediator of AICD in T cells. These different mechanisms of peripheral blood T cell apoptosis may play different roles in the pathogenesis of HIV infection.

Indexed as

Lymphocyte ActivationAntibodies, MonoclonalApoptosisApoptosis Regulatory ProteinsCaspase 1Cells, CulturedCysteine EndopeptidasesCysteine Proteinase Inhibitorsfas ReceptorHIV InfectionsHumansInterleukin-1LigandsMembrane GlycoproteinsT-Lymphocyte SubsetsTNF-Related Apoptosis-Inducing LigandAntibodies, MonoclonalApoptosis Regulatory ProteinsCaspase 1Cysteine EndopeptidasesCysteine Proteinase Inhibitorsfas ReceptorInterleukin-1LigandsMembrane GlycoproteinsTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID9334376
PMCPMC2199088
OpenAlexW2080375720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.